Rapid mAb Charge Variant Analysis with 20 mm Cation Exchange Columns

Importance of the Topic

High‐throughput charge variant analysis of monoclonal antibodies (mAbs) is critical for biopharmaceutical development, quality control, and manufacturing. Rapid assays reduce turnaround time, conserve reagents, and enhance process efficiency. Short-length cation exchange (CEX) columns offer a promising path to accelerate intact mAb profiling while maintaining sufficient resolution.

Objectives and Study Overview

This study evaluates a 6-minute CEX method for analyzing NISTmAb charge variants on a BioResolve™ Premier SCX mAb column (3 µm, 2.1 × 20 mm). Both salt and pH gradient elutions are compared to determine their separation efficiency, throughput gains, and suitability for routine high-throughput applications.

Methodology and Used Instrumentation

Sample preparation involved diluting NISTmAb RM 8671 to 2.5 mg/mL. Two gradient modes were applied:

• Salt gradient: 20 mM MES pH 6.7 (A) to 20 mM MES + 1 M NaCl pH 6.7 (B).
• pH gradient: diluted BioResolve CX concentrates from pH 5.0 (A) to pH 10.2 (B).

The LC system and conditions included:

• ACQUITY™ UPLC™ H-Class Bio with ACQUITY TUV detector at 280 nm.
• BioResolve Premier SCX mAb column, 2.1 × 20 mm, 3 µm.
• Flow rate: 0.3 mL/min; column temp: 30 °C; sample temp: 10 °C; injection: 1 µL.
• Data acquisition using Empower™ 3 software.

Results and Discussion

Both salt and pH gradients achieved mAb charge variant separations within six minutes. The pH gradient delivered improved resolution of acidic variants compared to the salt gradient, mirroring trends seen on longer columns. Relative to a conventional 4.6 × 50 mm CEX column, the 20 mm format showed reduced chromatographic detail, especially with salt elution, yet still met quality requirements for high-throughput screening. Ruggedness testing (500 pressure cycles from 0 to 4000 psi) revealed less than 4% loss in resolution, confirming column stability.

Benefits and Practical Applications

• Five-fold increase in sample throughput.
• Over ten-fold reduction in mobile phase and sample volume use.
• Short instrument runtimes, enabling efficient screening workflows.
• Robust column performance under repeated pressure cycling.

Future Trends and Opportunities

Growing demands for rapid biopharmaceutical analytics will drive further miniaturization of CEX columns and integration with mass spectrometry for detailed variant identification. Advances in gradient optimization—potentially aided by AI—will refine resolution in ultra-fast formats. Implementation within process analytical technology (PAT) frameworks can facilitate real-time monitoring of mAb charge profiles during production.

Conclusion

The 2.1 × 20 mm BioResolve Premier SCX mAb column enables six-minute charge variant analysis of intact mAbs with acceptable resolution trade-offs. The pH gradient approach offers enhanced separation of acidic species. Combined with significant solvent and sample savings, this method is well suited for high-throughput biopharmaceutical settings.

References

1. Fekete S. and Guillarme D. Ultra-short columns for the chromatographic analysis of large molecules. J Chrom A. 1706 (2023) 464285.
2. Navarro-Huerta J.A. et al. Ultra-Short Ion-Exchange Columns for Fast Charge Variants Analysis of Therapeutic Proteins. J Chrom A. 1657 (2021) 462568.
3. Yang H., Warren W., Koza S. AutoBlend Plus Technology for Ion-Exchange Chromatography Method Development and Robustness Testing. Waters Application Note 720006557 (2019).
4. Wang Q. et al. Development of pH Gradient Mobile Phase Concentrates for Robust, High Resolution mAb Charge Variant Analysis. Waters Application Note 720006491 (2019).